NxStage Medical

NxStage is more than just a company; we are leading the renal revolution. By our own design, we’re at the leading edge of a movement to transform renal care. To make it simpler. To make it portable. To expand treatment options for clinicians by overcoming traditional barriers. To enhance patient freedom and fulfillment. With significant breakthroughs already behind us - and others in the pipeline - NxStage is finding itself at the forefront of dramatically improved renal care, thanks to innovative yet simple therapeutic solutions that benefit patients, caregivers, and society. Our approach – and success is inspiring patients and providers.
Lawrence, US
3,600 (est)
NxStage Medical was founded in 1998 and is headquartered in Lawrence, US

NxStage Medical Locations

Lawrence, US
Minneapolis, US
Atlanta, US
Dallas, US
Boston, US
Dayton, US
Orange, US
Columbus, US
Indianapolis, US
St. Louis, US
San Francisco, US
Charleston, US
Philadelphia, US
Las Vegas, US
Memphis, US
Chicago, US
Monroeville, US
Coconut Creek, US
Oak Brook, US
Casselberry, US

NxStage Medical Metrics

NxStage Medical Summary

Market capitalization

$1.81 B

Closing share price

NxStage Medical's current market capitalization is $1.81 B.

NxStage Medical Financials

NxStage Medical's revenue is $336 M in FY, 2015 which is 11.48% increase from the previous period.
FY, 2013FY, 2014FY, 2015


$263 M$302 M$336 M

Gross profit

$103 M$116 M$131 M

Operating income

$-17.8 M$-22.2 M$-14.6 M

Operating expense total

$120 M$138 M$146 M

Net Income

$-18.6 M$-24.3 M$-16.3 M

Operating cash flow

$-22.3 M$-31.3 M$6.18 M

    NxStage Medical Market Value History

    NxStage Medical Online Presence

    NxStage Medical News

    NxStage Medical Company Life